Video | April 28, 2026

When Should You Rescue Your Clinical Trial From A Bad RTSM?

Source: Korio

Mid-study transitions are often avoided due to perceived risk, yet the long-term cost of sticking with a failing RTSM provider can be far higher. When software delays and poor vendor support begin to jeopardize site morale and data integrity, it is time to evaluate a rescue plan. This session breaks down how to audit your current partnership, assess the feasibility of a migration, and implement a structured transition that minimizes disruption. By prioritizing a smoother operational flow, teams can reclaim control over their timelines and eliminate daily friction.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader